Literature DB >> 26230283

HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.

Lyndsay Ann Richardson1, Mariam El-Zein1, Agnihotram V Ramanakumar1, Samuel Ratnam2,3, Ghislain Sangwa-Lugoma4, Adhemar Longatto-Filho5,6,7,8, Marly Augusto Cardoso9, Francois Coutlée10, Eduardo L Franco1.   

Abstract

BACKGROUND: Knowledge of cervical human papillomavirus (HPV) status might influence a cytotechnician's assessment of cellular abnormalities. The authors compared original cytotechnicians' Papanicolaou (Pap) readings for which HPV status was concealed with Pap rereads for which HPV status was revealed separately for 3 screening populations.
METHODS: Previously collected cervical Pap smears and clinical data were obtained from the Canadian Cervical Cancer Screening Trial (study A), the Democratic Republic of Congo Community-Based Screening Study (study B), and the Brazilian Investigation into Nutrition and Cervical Cancer Prevention (study C). Smears were reread with knowledge of HPV status for all HPV-positive women as well as a sample of HPV-negative women. Diagnostic performance of Pap cytology was compared between original readings and rereads.
RESULTS: A total of 1767 Pap tests were reread. Among 915 rereads for HPV-positive women, the contrast between "revealed" and "concealed" Pap readings demonstrated revisions from negative to positive results for 109 women (cutoff was atypical squamous cells of undetermined significance or worse) and 124 women (cutoff was low-grade squamous intraepithelial lesions [LSIL] or worse). For a disease threshold of cervical intraepithelial neoplasia of grade 2 or worse, specificity significantly declined at the atypical squamous cells of undetermined significance cutoff for studies A (86.6% to 75.3%) and C (42.5% to 15.5%), and at the LSIL cutoff for study C (61.9% to 37.6%). Sensitivity remained nearly unchanged between readings, except in study C, in which reread performance was superior (91.3% vs 71.9% for the LSIL cutoff).
CONCLUSIONS: A reduction in the diagnostic accuracy of Pap cytology was observed when revealing patients' cervical HPV status, possibly due to a heightened awareness of potential abnormalities, which led to more false-positive results.
© 2015 American Cancer Society.

Entities:  

Keywords:  Papanicolaou test; cervical cancer; human papillomavirus (HPV); screening

Mesh:

Substances:

Year:  2015        PMID: 26230283     DOI: 10.1002/cncy.21596

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  10 in total

1.  mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.

Authors:  Juan Luis Callejas-Valera; Ramiro Iglesias-Bartolome; Panomwat Amornphimoltham; Julia Palacios-Garcia; Daniel Martin; Joseph A Califano; Alfredo A Molinolo; J Silvio Gutkind
Journal:  Carcinogenesis       Date:  2016-08-18       Impact factor: 4.944

Review 2.  Triage of HPV positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen; Mark Schiffman; Timothy Palmer; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-11-28       Impact factor: 3.168

3.  A cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening.

Authors:  Hai-Rui Wang; Yu-Cong Li; Hui-Qin Guo; Lu-Lu Yu; Zeni Wu; Jian Yin; Guang-Dong Liao; Yi-Min Qu; Yu Jiang; Dong Wang; Wen Chen
Journal:  Oncotarget       Date:  2017-08-03

4.  Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Authors:  Nicole G Campos; Mercy Mvundura; Jose Jeronimo; Francesca Holme; Elisabeth Vodicka; Jane J Kim
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

5.  Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.

Authors:  Maribel Almonte; Raúl Murillo; Gloria Inés Sánchez; Paula González; Annabelle Ferrera; María Alejandra Picconi; Carolina Wiesner; Aurelio Cruz-Valdez; Eduardo Lazcano-Ponce; Jose Jerónimo; Catterina Ferreccio; Elena Kasamatsu; Laura Mendoza; Guillermo Rodríguez; Alejandro Calderón; Gino Venegas; Verónica Villagra; Silvio Tatti; Laura Fleider; Carolina Terán; Armando Baena; María de la Luz Hernández; Mary Luz Rol; Eric Lucas; Sylvaine Barbier; Arianis Tatiana Ramírez; Silvina Arrossi; María Isabel Rodríguez; Emmanuel González; Marcela Celis; Sandra Martínez; Yuly Salgado; Marina Ortega; Andrea Verónica Beracochea; Natalia Pérez; Margarita Rodríguez de la Peña; María Ramón; Pilar Hernández-Nevarez; Margarita Arboleda-Naranjo; Yessy Cabrera; Brenda Salgado; Laura García; Marco Antonio Retana; María Celeste Colucci; Javier Arias-Stella; Yenny Bellido-Fuentes; María Liz Bobadilla; Gladys Olmedo; Ivone Brito-García; Armando Méndez-Herrera; Lucía Cardinal; Betsy Flores; Jhacquelin Peñaranda; Josefina Martínez-Better; Ana Soilán; Jacqueline Figueroa; Benedicta Caserta; Carlos Sosa; Adrián Moreno; Juan Mural; Franco Doimi; Diana Giménez; Hernando Rodríguez; Oscar Lora; Silvana Luciani; Nathalie Broutet; Teresa Darragh; Rolando Herrero
Journal:  BMJ Open       Date:  2020-05-24       Impact factor: 2.692

6.  The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening.

Authors:  Clare A Aitken; Kim M Holtzer-Goor; Anne Uyterlinde; Adriaan Jc van den Brule; Hans C van der Linden; Cornelis J Huijsmans; Inge McM de Kok; Folkert J van Kemenade
Journal:  J Med Screen       Date:  2019-07-25       Impact factor: 2.136

7.  Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.

Authors:  Matejka Rebolj; Christopher S Mathews; Karin Denton
Journal:  Cancer Cytopathol       Date:  2022-04-04       Impact factor: 4.264

8.  High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.

Authors:  Weijing Zhang; Weiling He; Yongjie Shi; Haifeng Gu; Min Li; Zhimin Liu; Yanling Feng; Nianzhen Zheng; Chuanmiao Xie; Yanna Zhang
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

9.  Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.

Authors:  Wina Verlaat; Robert W Van Leeuwen; Putri W Novianti; Ed Schuuring; Chris J L M Meijer; Ate G J Van Der Zee; Peter J F Snijders; Daniëlle A M Heideman; Renske D M Steenbergen; G Bea A Wisman
Journal:  Epigenetics       Date:  2018-08-24       Impact factor: 4.528

10.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.